Citation Impact
Citing Papers
Structure and binding kinetics of three different human CD1d–α-galactosylceramide–specific T cell receptors
2006
Removing T-cell epitopes with computational protein design
2014 StandoutNobel
Innate and Adaptive Immunity Cooperate Flexibly to Maintain Host-Microbiota Mutualism
2009 StandoutScienceNobel
Mouse Vα14 i natural killer T cells are resistant to cytokine polarization in vivo
2003
Editing of CD1d-Bound Lipid Antigens by Endosomal Lipid Transfer Proteins
2003 Science
The Paradox of Immune Molecular Recognition of α-Galactosylceramide: Low Affinity, Low Specificity for CD1d, High Affinity for αβ TCRs
2003
The crystal structure of human CD1d with and without α-galactosylceramide
2005
CD1d-restricted mouse Vα14 and human Vα24 T cells: lymphocytes of innate immunity
2000
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
2001 StandoutNature
Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections
2005 StandoutNatureNobel
Cell wall glycosphingolipids ofSphingomonas paucimobilisare CD1d-specific ligands for NKT cells
2005
Inhibition of antitumor immunity by invariant natural killer T cells in a T‐cell lymphoma model in vivo
2006
Stem cells, cancer, and cancer stem cells
2001 StandoutNature
ITAM-mediated tonic signalling through pre-BCR and BCR complexes
2006
Thymocyte expression of cathepsin L is essential for NKT cell development
2002
Presentation of self and microbial lipids by CD1 molecules
2001
DNA vaccine with α-galactosylceramide at prime phase enhances anti-tumor immunity after boosting with antigen-expressing dendritic cells
2010
Marginal-zone B cells
2002
Requirement for Notch1 signals at sequential early stages of intrathymic T cell development
2005
Prolonged IFN-γ–producing NKT response induced with α-galactosylceramide–loaded DCs
2002 StandoutNobel
Recognition of microorganisms and activation of the immune response
2007 StandoutNature
Integrins Form an Expanding Diffusional Barrier that Coordinates Phagocytosis
2016 StandoutNobel
Lipid length controls antigen entry into endosomal and nonendosomal pathways for CD1b presentation
2002
B-cell–lineage immunogen design in vaccine development with HIV-1 as a case study
2012
Immunization with α-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis
1999
Saposins facilitate CD1d-restricted presentation of an exogenous lipid antigen to T cells
2004
IgA production without μ or δ chain expression in developing B cells
2001
AID is required for germinal center–derived lymphomagenesis
2007 StandoutNobel
Murine CD1d-Restricted T Cell Recognition of Cellular Lipids
2000
Interdependent IL-7 and IFN-γ signalling in T-cell controls tumour eradication by combined α-CTLA-4+α-PD-1 therapy
2016 StandoutNobel
α-Galactosylceramide Induces Early B-Cell Activation through IL-4 Production by NKT Cells
2000
Positive Selection from Newly Formed to Marginal Zone B Cells Depends on the Rate of Clonal Production, CD19, and btk
2000
IgA responses in the intestinal mucosa against pathogenic and non-pathogenic microorganisms
2001
Molecular biology of NK T cell specificity and development
2000
CD1-restricted T-cell responses and microbial infection
2000 Nature
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Regulation of intracellular trafficking of human CD1d by association with MHC class II molecules
2002
The unconventional lifestyle of NKT cells
2002
Transforming growth factor-β induces development of the TH17 lineage
2006 StandoutNature
Metazoan MicroRNAs
2018 Standout
Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells
2000
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
CD1d function is regulated by microsomal triglyceride transfer protein
2004
Calnexin, Calreticulin, and ERp57 Cooperate in Disulfide Bond Formation in Human CD1d Heavy Chain
2002
Immunity, Inflammation, and Cancer
2010 Standout
TGF-β Receptor Controls B Cell Responsiveness and Induction of IgA In Vivo
2000
Naive and memory B cells in T-cell-dependent and T-independent responses
2001
Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity
2000
Marginal Zone and B1 B Cells Unite in the Early Response against T-Independent Blood-Borne Particulate Antigens
2001
TGFβ in Cancer
2008 Standout
The Protean Nature of Cells in the B Lymphocyte Lineage
2007
The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cells
2004
NKT cells: facts, functions and fallacies
2000
Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages
2007 StandoutNobel
Structurally Distinct Phosphatases CD45 and CD148 Both Regulate B Cell and Macrophage Immunoreceptor Signaling
2008
Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor
2005
Glycolipids and phospholipids as natural CD1d-binding NKT cell ligands
2006
A Dominant Complement Fixation Pathway for Pneumococcal Polysaccharides Initiated by SIGN-R1 Interacting with C1q
2006 StandoutNobel
Autoreactivity by design: innate B and T lymphocytes
2001
Atherosclerosis
2000 StandoutNature
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
2001 StandoutNature
A modified α-galactosyl ceramide for staining and stimulating natural killer T cells
2006
Wnt signalling in stem cells and cancer
2005 StandoutNature
Multiple defects in antigen presentation and T cell development by mice expressing cytoplasmic tail–truncated CD1d
2001
Atherosclerosis
2001 Standout
Investigating Mitochondrial Redox Potential with Redox-sensitive Green Fluorescent Protein Indicators
2004 StandoutNobel
Regulation of CD1d expression and function by a herpesvirus infection
2005
NKT cells derive from double-positive thymocytes that are positively selected by CD1d
2001
Microinjected glutathione reductase crystals as indicators of the redox status in living cells
1999
Tissue-Specific Segregation of CD1d-Dependent and CD1d-Independent NK T Cells
1999
NKT Cells Enhance CD4+ and CD8+ T Cell Responses to Soluble Antigen In Vivo through Direct Interaction with Dendritic Cells
2003
Glycolipid Antigen Processing for Presentation by CD1d Molecules
2001 Science
The Regulatory Role of Vα14 NKT Cells in Innate and Acquired Immune Response
2003
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
Defective presentation of the CD1d1-restricted natural Va14Ja18 NKT lymphocyte antigen caused by β-d -glucosylceramide synthase deficiency
2003
Inhibition of glycolipid shedding rescues recognition of a CD1+T cell lymphoma by natural killer T (NKT) cells
2002
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
Differential Requirement for Rel/Nuclear Factor κB Family Members in Natural Killer T Cell Development
2003
Burkitt Lymphoma in the Mouse
2000
Notch 1–Deficient Common Lymphoid Precursors Adopt a B Cell Fate in the Thymus
2001
Activation-induced cytidine deaminase (AID) promotes B cell lymphomagenesis in Emu-cmyc transgenic mice
2007 StandoutNobel
Cross-presentation of glycolipid from tumor cells loaded with α-galactosylceramide leads to potent and long-lived T cell–mediated immunity via dendritic cells
2007 StandoutNobel
Mechanisms imposing the Vβ bias of Vα14 natural killer T cells and consequences for microbial glycolipid recognition
2006
Conserved and Heterogeneous Lipid Antigen Specificities of CD1d-Restricted NKT Cell Receptors
2006
CD1d Ligands: The Good, the Bad, and the Ugly
2006
Cutting Edge: Influence of the TCR Vβ Domain on the Selection of Semi-Invariant NKT Cells by Endogenous Ligands
2006
The Biology of NKT Cells
2006 Standout
The Vα14 NKT Cell TCR Exhibits High-Affinity Binding to a Glycolipid/CD1d Complex
2002
Cutting edge: activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype.
1999
The C-type lectin SIGN-R1 mediates uptake of the capsular polysaccharide ofStreptococcus pneumoniaein the marginal zone of mouse spleen
2003 StandoutNobel
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
2013 StandoutScienceNobel
Design of natural killer T cell activators: Structure and function of a microbial glycosphingolipid bound to mouse CD1d
2006
Sequential production of interferon-γ by NK1.1+ T cells and natural killer cells is essential for the antimetastatic effect of α-galactosylceramide
2002
NKT Cells in the Rat: Organ-Specific Distribution of NK T Cells Expressing Distinct Vα14 Chains
2000
Analysis of Human Vα24+ CD4+ NKT Cells Activated by α-Glycosylceramide-Pulsed Monocyte-Derived Dendritic Cells
2000
Innate Vα14+ natural killer T cells mature dendritic cells, leading to strong adaptive immunity
2007 StandoutNobel
Dendritic Cell Maturation Overrules H-2d–Mediated Natural Killer T (Nkt) Cell Inhibition
2001
A Subset of Liver NK T Cells Is Activated duringLeishmania donovaniInfection by CD1d-bound Lipophosphoglycan
2004
Membrane Lymphotoxin Is Required for the Development of Different Subpopulations of NK T Cells
2000
Frizzled 9 knock-out mice have abnormal B-cell development
2004
Activation of Natural Killer T Cells by α-Galactosylceramide Rapidly Induces the Full Maturation of Dendritic Cells In Vivo and Thereby Acts as an Adjuvant for Combined CD4 and CD8 T Cell Immunity to a Coadministered Protein
2003 StandoutNobel
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Two distinctive pathways for recruitment of naïve and primed IgM+B cells to the gut lamina propria
2005 StandoutNobel
α-Galactosylceramide-activated Vα14 natural killer T cells mediate protection against murine malaria
2000
IFN-gamma-mediated inhibition of tumor angiogenesis by natural killer T-cell ligand, alpha-galactosylceramide.
2002
THE CD1 SYSTEM: Antigen-Presenting Molecules for T Cell Recognition of Lipids and Glycolipids
1999
Lipid Protein Interactions: The Assembly of CD1d1 with Cellular Phospholipids Occurs in the Endoplasmic Reticulum
2002
Cutting Edge: Activation of NK T Cells by CD1d and α-Galactosylceramide Directs Conventional T Cells to the Acquisition of a Th2 Phenotype
1999
Identification of antigen-presenting dendritic cells in mouse aorta and cardiac valves
2009 StandoutNobel
Glycolipid Antigen Drives Rapid Expansion and Sustained Cytokine Production by NK T Cells
2003
Critical contribution of IFN-γ and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of α-galactosylceramide
2001
Critical Roles of Pten in B Cell Homeostasis and Immunoglobulin Class Switch Recombination
2003 StandoutNobel
Natural Killer T Cell Activation Inhibits Hepatitis B Virus Replication in Vivo
2000
The Linkage of Innate to Adaptive Immunity via Maturing Dendritic Cells In Vivo Requires CD40 Ligation in Addition to Antigen Presentation and CD80/86 Costimulation
2004 StandoutNobel
Tracking the Response of Natural Killer T Cells to a Glycolipid Antigen Using Cd1d Tetramers
2000
Cutting Edge: The Ontogeny and Function of Va14Ja18 Natural T Lymphocytes Require Signal Processing by Protein Kinase Cθ and NF-κB
2004
CD1d-Specific NK1.1+ T Cells with a Transgenic Variant TCR
2000
Cutting Edge: Influence of the TCR Vβ Domain on the Avidity of CD1d:α-Galactosylceramide Binding by Invariant Vα14 NKT Cells
2003
A structural basis for selection and cross-species reactivity of the semi-invariant NKT cell receptor in CD1d/glycolipid recognition
2006
The Mouse Cd1d-Restricted Repertoire Is Dominated by a Few Autoreactive T Cell Receptor Families
2001
B Cell Development Pathways
2001
Glycolipid α-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice
2006 StandoutNobel
Natural Killer T Cell Activation Protects Mice Against Experimental Autoimmune Encephalomyelitis
2001
Dendritic cell maturation by innate lymphocytes
2005 StandoutNobel
Presentation of peptide antigens by mouse CD1 requires endosomal localization and protein antigen processing
1998
The Peritoneal Cavity Provides a Protective Niche for B1 and Conventional B Lymphocytes during Anti-CD20 Immunotherapy in Mice
2005
A Natural Killer T (NKT) Cell Developmental Pathway Involving a Thymus-dependent NK1.1−CD4+ CD1d-dependent Precursor Stage
2002
Unique potential of 4-1BB agonist antibody to promote durable regression of HPV + tumors when combined with an E6/E7 peptide vaccine
2015 StandoutNobel
Msx2-interacting nuclear target protein (Mint) deficiency reveals negative regulation of early thymocyte differentiation by Notch/RBP-J signaling
2007 StandoutNobel
Critical contribution of IFN-gamma and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of alpha-galactosylceramide.
2001
Regulation of CD1d expression and function by a herpesvirus infection
2005
Quantitative and Qualitative Differences in the In Vivo Response of NKT Cells to Distinct α- and β-Anomeric Glycolipids
2004
Anatomy of CD1–lipid antigen complexes
2005
T-Independent Immune Response: New Aspects of B Cell Biology
2000 StandoutScienceNobel
The Danger Model: A Renewed Sense of Self
2002 StandoutScience
Abnormal B lymphocyte development and autoimmunity in hypoxia-inducible factor 1α-deficient chimeric mice
2002 StandoutNobel
Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum
2011 StandoutScience
Human NKT Cells Mediate Antitumor Cytotoxicity Directly by Recognizing Target Cell CD1d with Bound Ligand or Indirectly by Producing IL-2 to Activate NK Cells
2001
CD1d-mediated Recognition of an α-Galactosylceramide by Natural Killer T Cells Is Highly Conserved through Mammalian Evolution
1998
Homeostasis of Peripheral B Cells in the Absence of B Cell Influx from the Bone Marrow
2001
Cutting edge: inhibition of experimental tumor metastasis by dendritic cells pulsed with alpha-galactosylceramide.
1999
TRANSFORMING GROWTH FACTOR-β REGULATION OF IMMUNE RESPONSES
2005 Standout
Notch2 Haploinsufficiency Results in Diminished B1 B Cells and a Severe Reduction in Marginal Zone B Cells
2003
CD1 expression is differentially regulated by microglia, macrophages and T cells in the central nervous system upon inflammation and demyelination
2001
Costimulation-Dependent Modulation of Experimental Autoimmune Encephalomyelitis by Ligand Stimulation of Vα14 NK T Cells
2001
From hematopoiesis to neuropoiesis: Evidence of overlapping genetic programs
2001
The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cells
2004
A unique lymphotoxin αβ-dependent pathway regulates thymic emigration of Vα14 invariant natural killer T cells
2006
Origins and Functions of B-1 Cells with Notes on the Role of CD5
2002
Tolerogenic Dendritic Cells
2003 StandoutNobel
PapA1 and PapA2 are acyltransferases essential for the biosynthesis of theMycobacterium tuberculosisvirulence factor Sulfolipid-1
2007 StandoutNobel
CD1: Antigen Presentation and T Cell Function
2004
Noncytolytic Control of Viral Infections by the Innate and Adaptive ImmuneResponse
2001
NIK-dependent RelB Activation Defines a Unique Signaling Pathway for the Development of Vα14i NKT Cells
2003
Sustained expansion of NKT cells and antigen-specific T cells after injection of α-galactosyl-ceramide loaded mature dendritic cells in cancer patients
2005 StandoutNobel
Cutting Edge Commentary: Origins of B-1 Cells
2001
Protein-Sulfenic Acids: Diverse Roles for an Unlikely Player in Enzyme Catalysis and Redox Regulation
1999
Differential Tumor Surveillance by Natural Killer (Nk) and Nkt Cells
2000
miR-150 regulates the development of NK and iNKT cells
2011
The Mouse CD1d Cytoplasmic Tail Mediates CD1d Trafficking and Antigen Presentation by Adaptor Protein 3-Dependent and -Independent Mechanisms
2005
The Pten/PI3K pathway governs the homeostasis of Vα14iNKT cells
2006 StandoutNobel
Cutting Edge: Inhibition of Experimental Tumor Metastasis by Dendritic Cells Pulsed with α-Galactosylceramide
1999
Activating Immunity in the Liver. I. Liver Dendritic Cells (but Not Hepatocytes) Are Potent Activators of IFN-γ Release by Liver NKT Cells
2001
Cross-presentation of Disialoganglioside GD3 to Natural Killer T Cells
2003
The Natural Killer T (NKT) Cell Ligand α-Galactosylceramide Demonstrates Its Immunopotentiating Effect by Inducing Interleukin (IL)-12 Production by Dendritic Cells and IL-12 Receptor Expression on NKT Cells
1999
Works of Ming Gui being referenced
Inhibition of Human Glutathione Reductase by S‐nitrosoglutathione
1995
Redox processes in malaria and other parasitic diseases
1994
Selective Ability of Mouse CD1 to Present Glycolipids: α-Galactosylceramide Specifically Stimulates Vα14+ NK T Lymphocytes
1998
B‐cell commitment, development and selection
2000
Positive Selection of Anti–Thy-1 Autoreactive B-1 Cells and Natural Serum Autoantibody Production Independent from Bone Marrow B Cell Development
2003
Recycling CD1d1 Molecules Present Endogenous Antigens Processed in an Endocytic Compartment to NKT Cells
2002
Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes.
1998
TCRβ Chain Influences But Does Not Solely Control Autoreactivity of Vα14J281T Cells
2001
Peripheral CD4+ T Cell Maturation Recognized by Increased Expression of Thy-1/CD90 Bearing the 6C10 Carbohydrate Epitope
1999
Positive Selection of Natural Autoreactive B Cells
1999 Science
Structural requirements for antigen presentation by mouse CD1
2000